Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P14
Within normal range
vs 2Y Ago
-2.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -74.30% |
| 2023 | 58.23% |
| 2022 | 30.01% |
| 2021 | -24.07% |
| 2020 | -52.62% |
| 2019 | -179.94% |
| 2018 | -20.22% |
| 2017 | 0.00% |